PCRX logo

Pacira BioSciences, Inc. (PCRX) Operating Profit

Annual Operating Profit:

$97.57M+$10.25M(+11.74%)
December 31, 2024

Summary

  • As of today, PCRX annual operating income is $97.57 million, with the most recent change of +$10.25 million (+11.74%) on December 31, 2024.
  • During the last 3 years, PCRX annual operating profit has fallen by -$35.26 million (-26.54%).
  • PCRX annual operating profit is now -26.54% below its all-time high of $132.84 million, reached on December 31, 2021.

Performance

PCRX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCRXincome statement metrics

Quarterly Operating Profit:

$13.15M+$4.02M(+44.02%)
September 30, 2025

Summary

  • As of today, PCRX quarterly operating income is $13.15 million, with the most recent change of +$4.02 million (+44.02%) on September 30, 2025.
  • Over the past year, PCRX quarterly operating profit has dropped by -$8.80 million (-40.08%).
  • PCRX quarterly operating profit is now -70.68% below its all-time high of $44.87 million, reached on December 31, 2021.

Performance

PCRX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCRXincome statement metrics

TTM Operating Profit:

$60.00M-$8.80M(-12.79%)
September 30, 2025

Summary

  • As of today, PCRX TTM operating income is $60.00 million, with the most recent change of -$8.80 million (-12.79%) on September 30, 2025.
  • Over the past year, PCRX TTM operating profit has dropped by -$42.01 million (-41.18%).
  • PCRX TTM operating profit is now -54.65% below its all-time high of $132.30 million, reached on March 31, 2022.

Performance

PCRX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCRXincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

PCRX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+11.7%-40.1%-41.2%
3Y3 Years-26.5%-39.6%-40.9%
5Y5 Years+173.2%-28.2%+47.6%

PCRX Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-26.5%+37.6%-61.3%+60.9%-41.2%+3.1%
5Y5-Year-26.5%+173.2%-70.7%+60.9%-54.6%+47.6%
All-TimeAll-Time-26.5%+283.1%-70.7%+162.7%-54.6%+196.5%

PCRX Operating Profit History

DateAnnualQuarterlyTTM
Sep 2025
-
$13.15M(+44.0%)
$60.00M(-12.8%)
Jun 2025
-
$9.13M(+11.7%)
$68.79M(-24.1%)
Mar 2025
-
$8.18M(-72.3%)
$90.64M(-7.1%)
Dec 2024
$97.57M(+11.7%)
$29.53M(+34.6%)
$97.57M(-4.3%)
Sep 2024
-
$21.95M(-29.1%)
$102.01M(+0.9%)
Jun 2024
-
$30.98M(+104.9%)
$101.13M(+8.3%)
Mar 2024
-
$15.12M(-55.5%)
$93.42M(+7.0%)
Dec 2023
$87.32M(+23.1%)
$33.97M(+61.2%)
$87.32M(+29.2%)
Sep 2023
-
$21.08M(-9.4%)
$67.60M(-1.0%)
Jun 2023
-
$23.26M(+158.0%)
$68.30M(+17.3%)
Mar 2023
-
$9.02M(-36.7%)
$58.21M(-17.9%)
Dec 2022
$70.93M(-46.6%)
$14.24M(-34.6%)
$70.93M(-30.2%)
Sep 2022
-
$21.78M(+65.3%)
$101.55M(-8.1%)
Jun 2022
-
$13.18M(-39.4%)
$110.49M(-16.5%)
Mar 2022
-
$21.73M(-51.6%)
$132.30M(+0.3%)
Dec 2021
$132.84M(+157.9%)
$44.87M(+46.1%)
$131.88M(+17.2%)
Sep 2021
-
$30.72M(-12.2%)
$112.57M(+12.4%)
Jun 2021
-
$34.99M(+64.2%)
$100.16M(+68.5%)
Mar 2021
-
$21.31M(-16.6%)
$59.44M(+15.4%)
Dec 2020
$51.52M(+44.3%)
$25.55M(+39.5%)
$51.52M(+26.7%)
Sep 2020
-
$18.31M(+419.6%)
$40.65M(+25.6%)
Jun 2020
-
-$5.73M(-142.8%)
$32.37M(-30.8%)
Mar 2020
-
$13.39M(-8.8%)
$46.77M(+35.6%)
Dec 2019
$35.71M(+45.3%)
$14.68M(+46.3%)
$34.50M(+7.4%)
Sep 2019
-
$10.03M(+15.6%)
$32.13M(+17.2%)
Jun 2019
-
$8.68M(+683.4%)
$27.41M(+7.8%)
Mar 2019
-
$1.11M(-91.0%)
$25.43M(+45.5%)
Dec 2018
$24.58M(+289.5%)
$12.31M(+132.1%)
$17.48M(+27.2%)
Sep 2018
-
$5.31M(-20.8%)
$13.74M(+168.3%)
Jun 2018
-
$6.70M(+197.9%)
$5.12M(+139.8%)
Mar 2018
-
-$6.85M(-179.8%)
-$12.87M(+35.9%)
Dec 2017
-$12.97M
$8.58M(+359.0%)
-$20.07M(+35.5%)
Sep 2017
-
-$3.31M(+70.7%)
-$31.11M(+36.2%)
DateAnnualQuarterlyTTM
Jun 2017
-
-$11.29M(+19.7%)
-$48.76M(-11.0%)
Mar 2017
-
-$14.05M(-470.9%)
-$43.92M(-36.7%)
Dec 2016
-$24.92M(-363.6%)
-$2.46M(+88.3%)
-$32.12M(-8.3%)
Sep 2016
-
-$20.96M(-225.3%)
-$29.66M(-726.5%)
Jun 2016
-
-$6.44M(-185.9%)
-$3.59M(-176.8%)
Mar 2016
-
-$2.25M(-144.1%)
$4.67M(-74.3%)
Dec 2015
$9.46M(+283.1%)
-
-
Sep 2015
-
$5.11M(+181.0%)
$18.19M(+50.4%)
Jun 2015
-
$1.82M(-45.6%)
$12.09M(+62.7%)
Mar 2015
-
$3.34M(-57.8%)
$7.43M(+243.9%)
Dec 2014
-$5.17M(+90.3%)
$7.92M(+904.1%)
-$5.17M(+77.4%)
Sep 2014
-
-$985.00K(+65.3%)
-$22.90M(+34.1%)
Jun 2014
-
-$2.84M(+69.3%)
-$34.73M(+20.9%)
Mar 2014
-
-$9.26M(+5.7%)
-$43.90M(+17.6%)
Dec 2013
-$53.29M(-8.1%)
-$9.82M(+23.4%)
-$53.29M(+10.1%)
Sep 2013
-
-$12.81M(-6.7%)
-$59.30M(+4.7%)
Jun 2013
-
-$12.01M(+35.6%)
-$62.19M(-9.5%)
Mar 2013
-
-$18.64M(-17.8%)
-$56.81M(-15.2%)
Dec 2012
-$49.30M(-36.6%)
-$15.83M(-0.8%)
-$49.30M(-9.1%)
Sep 2012
-
-$15.71M(-137.0%)
-$45.17M(-18.3%)
Jun 2012
-
-$6.63M(+40.5%)
-$38.19M(+4.8%)
Mar 2012
-
-$11.14M(+4.8%)
-$40.10M(-11.1%)
Dec 2011
-$36.08M(-61.3%)
-$11.70M(-34.0%)
-$36.08M(-20.0%)
Sep 2011
-
-$8.73M(-2.4%)
-$30.07M(+20.9%)
Jun 2011
-
-$8.53M(-19.8%)
-$38.02M(-8.3%)
Mar 2011
-
-$7.12M(-25.4%)
-$35.12M(-7.7%)
Dec 2010
-$22.37M(+21.6%)
-$5.68M(+66.0%)
-$32.62M(+6.1%)
Sep 2010
-
-$16.69M(-196.6%)
-$34.74M(-43.7%)
Jun 2010
-
-$5.63M(-22.0%)
-$24.17M(-30.3%)
Mar 2010
-
-$4.62M(+40.9%)
-$18.55M(-33.1%)
Dec 2009
-$28.55M(+37.1%)
-$7.81M(-27.6%)
-$13.93M(-127.6%)
Sep 2009
-
-$6.12M
-$6.12M
Dec 2008
-$45.36M(-74.6%)
-
-
Dec 2007
-$25.99M
-
-

FAQ

  • What is Pacira BioSciences, Inc. annual operating income?
  • What is the all-time high annual operating profit for Pacira BioSciences, Inc.?
  • What is Pacira BioSciences, Inc. annual operating profit year-on-year change?
  • What is Pacira BioSciences, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Pacira BioSciences, Inc.?
  • What is Pacira BioSciences, Inc. quarterly operating profit year-on-year change?
  • What is Pacira BioSciences, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Pacira BioSciences, Inc.?
  • What is Pacira BioSciences, Inc. TTM operating profit year-on-year change?

What is Pacira BioSciences, Inc. annual operating income?

The current annual operating profit of PCRX is $97.57M

What is the all-time high annual operating profit for Pacira BioSciences, Inc.?

Pacira BioSciences, Inc. all-time high annual operating income is $132.84M

What is Pacira BioSciences, Inc. annual operating profit year-on-year change?

Over the past year, PCRX annual operating income has changed by +$10.25M (+11.74%)

What is Pacira BioSciences, Inc. quarterly operating income?

The current quarterly operating profit of PCRX is $13.15M

What is the all-time high quarterly operating profit for Pacira BioSciences, Inc.?

Pacira BioSciences, Inc. all-time high quarterly operating income is $44.87M

What is Pacira BioSciences, Inc. quarterly operating profit year-on-year change?

Over the past year, PCRX quarterly operating income has changed by -$8.80M (-40.08%)

What is Pacira BioSciences, Inc. TTM operating income?

The current TTM operating profit of PCRX is $60.00M

What is the all-time high TTM operating profit for Pacira BioSciences, Inc.?

Pacira BioSciences, Inc. all-time high TTM operating income is $132.30M

What is Pacira BioSciences, Inc. TTM operating profit year-on-year change?

Over the past year, PCRX TTM operating income has changed by -$42.01M (-41.18%)
On this page